about
Current nanotechnology approaches for the treatment and management of diabetic retinopathy.Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems.Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials.Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate.Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.Predictive modeling of insulin release profile from cross-linked chitosan microspheres.Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process.A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing.The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune DiseasesPreparation and characterization of PEG-coated silica nanoparticles for oral insulin deliverySurface engineering of silica nanoparticles for oral insulin delivery: Characterization and cell toxicity studiesCross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testingThe Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules DeliveryComparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell linesOptimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line
P50
Q38298988-DF15D73A-3F86-4618-80FB-C9DB8AE6B40CQ38380118-E904E4E8-D32C-435E-9598-8971785B64F8Q38671259-B9758167-3B1D-4D08-96DB-29BC3EFC232FQ39055118-7481DEBD-942F-4821-862D-23B12162C499Q39115448-6A68C4DB-6D5E-4D84-9ABD-7D857F916821Q41114394-5CABE2D6-976E-42A4-8DEF-25670F735143Q42519746-CFD039B3-B1B9-4C20-8DAD-955F591477BAQ50450249-CEA58937-EB72-42E1-8B8F-BFD129B5FFF8Q50875255-3ADF0946-5727-4857-9E20-5DCB9C9CF3CCQ51060625-E2050722-B646-4B8F-9BEB-94FD0963F4A8Q51277492-77F2A8CF-2482-4AD1-8D21-94BB3C53B418Q51346953-0BC93522-0EF2-4B4B-882F-AEE2D24EF5ACQ52723528-3D113960-FA34-4B26-8386-97F8B5C484A3Q57826284-97CCD87F-C56D-4C9D-9A72-ED4D8B07F80BQ60587487-46772E02-2CFE-457F-ACFF-95636729FAEEQ60587495-3A261AB2-E2DC-4D56-AA32-4A0DBD27AE3DQ62002688-8012B369-146D-4AB1-8CCF-AF53D82AE933Q92258236-6D64D825-23E2-4A50-B1EF-3F884D95C292Q92772311-F5F891BF-D58F-4332-BEA7-0C3921EFBDA5Q93377158-00E79524-8B9A-4962-9479-D559EF213856
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joana F. Fangueiro
@ast
Joana F. Fangueiro
@en
Joana F. Fangueiro
@es
Joana F. Fangueiro
@sl
type
label
Joana F. Fangueiro
@ast
Joana F. Fangueiro
@en
Joana F. Fangueiro
@es
Joana F. Fangueiro
@sl
prefLabel
Joana F. Fangueiro
@ast
Joana F. Fangueiro
@en
Joana F. Fangueiro
@es
Joana F. Fangueiro
@sl
P106
P1153
37261124000
P21
P31
P496
0000-0001-6544-3943